EGFR and colorectal carcinoma: Additionally, it suppresses the EGFR/PI3K/Akt pathway and inhibits CRC development by inducing the transcription factors EGFR, PI3K, p‐mTOR, p‐Akt, p‐NF‐kB, and p‐P70S6.